<?xml version="1.0" encoding="UTF-8"?>
<rdf:RDF xmlns:rdf="http://www.w3.org/1999/02/22-rdf-syntax-ns#" xmlns:dcterms="http://purl.org/dc/terms/" xmlns:prism="http://prismstandard.org/namespaces/1.2/basic/" xmlns:dc="http://purl.org/dc/elements/1.1/" xmlns="http://purl.org/rss/1.0/"><channel rdf:about="http://www.precon-journal.com/?rss=yes"><title>CVD Prevention and Control</title><description>CVD Prevention and Control RSS feed: Current Issue. 
 CVD Prevention and Control  seeks to provide a forum for dialogue and education on matters that relate foremost to the prevention 
and control of cardiovascular diseases worldwide, with a special focus on countries with middle and lower economies. With the main focus 
being on prevention, manuscripts should address not only the extent or epidemiology of the problem, but also describe interventions to 
effectively control and prevent cardiovascular diseases and their antecedent factors. The emphasis should be on approaches that can be 
applied in settings with limited resources. Economic evaluations of successful interventions will be particularly welcome. Important 
negative findings will also be considered. While reports of hospital or clinic-based treatments will not necessarily be rejected, particularly 
if they have broad implications for cost-effective disease control or prevention, manuscripts that address community-based activities 
will be preferred. Submissions on cardiovascular surveillance and health policies, professional education, ethical issues and technological 
innovations particularly those related to prevention are encouraged. 
 
WHF Members and personal subscribers can access the journal 
online  here 
 
 
 Electronic usage: 
 
 
An increasing number 
of readers access the journal online via ScienceDirect, one of the world's most advanced web delivery systems for scientific, technical 
and medical information. 
 
Average monthly article downloads for this journal:  534* 
 
  * Figure is an average based 
on full text articles downloaded monthly via ScienceDirect between August 2008 and March 2009 
</description><link>http://www.precon-journal.com/?rss=yes</link><dc:publisher>Elsevier Inc.</dc:publisher><dc:language>en</dc:language><dc:rights> © 2010 World Heart Federation. Published by Elsevier Inc. All rights reserved. </dc:rights><prism:publicationName>CVD Prevention and Control</prism:publicationName><prism:issn>1875-4570</prism:issn><prism:volume>5</prism:volume><prism:number>2</prism:number><prism:publicationDate>June 2010</prism:publicationDate><prism:copyright> © 2010 World Heart Federation. Published by Elsevier Inc. All rights reserved. </prism:copyright><prism:rightsAgent>healthpermissions@elsevier.com</prism:rightsAgent><items><rdf:Seq><rdf:li rdf:resource="http://www.precon-journal.com/article/PIIS1875457010000586/abstract?rss=yes"/><rdf:li rdf:resource="http://www.precon-journal.com/article/PIIS1875457010000549/abstract?rss=yes"/><rdf:li rdf:resource="http://www.precon-journal.com/article/PIIS1875457010000550/abstract?rss=yes"/><rdf:li rdf:resource="http://www.precon-journal.com/article/PIIS1875457010000574/abstract?rss=yes"/><rdf:li rdf:resource="http://www.precon-journal.com/article/PIIS1875457010000562/abstract?rss=yes"/><rdf:li rdf:resource="http://www.precon-journal.com/article/PIIS1875457010000689/abstract?rss=yes"/></rdf:Seq></items></channel><item rdf:about="http://www.precon-journal.com/article/PIIS1875457010000586/abstract?rss=yes"><title>Metabolic obesity: A new therapeutic target for cardio-metabolic risk reduction</title><link>http://www.precon-journal.com/article/PIIS1875457010000586/abstract?rss=yes</link><description>Summary: During the last couple of years, the focus of attention has drifted from coronary risk to cardio-metabolic risk because of the growing epidemic of cardio-metabolic disorders such as obesity, metabolic syndrome, diabetes, and cardiovascular disease (CVD). Physical inactivity and consumption of high-energy foods are the root causes of this epidemic.</description><dc:title>Metabolic obesity: A new therapeutic target for cardio-metabolic risk reduction</dc:title><dc:creator>P.C. Manoria, Pankaj Manoria, Piyush Manoria</dc:creator><dc:identifier>10.1016/j.cvdpc.2010.05.002</dc:identifier><dc:source>CVD Prevention and Control 5, 2 (2010)</dc:source><dc:date>2010-06-14</dc:date><prism:publicationName>CVD Prevention and Control</prism:publicationName><prism:publicationDate>2010-06-14</prism:publicationDate><prism:volume>5</prism:volume><prism:number>2</prism:number><prism:issueIdentifier>S1875-4570(10)X0004-3</prism:issueIdentifier><prism:section>Review</prism:section><prism:startingPage>39</prism:startingPage><prism:endingPage>44</prism:endingPage></item><item rdf:about="http://www.precon-journal.com/article/PIIS1875457010000549/abstract?rss=yes"><title>The effect of hypertension, aging and benidipine on arterial elasticity in elderly hypertensives</title><link>http://www.precon-journal.com/article/PIIS1875457010000549/abstract?rss=yes</link><description>Summary: Four hundred and 16 subjects (average age, 56.2years; range, 20–92years; Men/Women, 207/209) undergoing annual health check-up were studied for the effect of aging and hypertension on arterial compliance or elasticity index, which were measured after a 10min rest in the supine position using CR-2000. Thirteen additional elderly patients with hypertension were also studied at rest in the supine position 30min before and after 8mg benidipine oral administration at the beginning of treatment and then repeatedly studied after a 10min rest over at least 4–7weeks to examine the effect of benidipine hydrochloride 8mg on arterial compliance in a similar manner. Systolic blood pressure and pulse pressure were increased in subjects above 40years of age. Diastolic blood pressure was also increased up to 60years of age but after 60years of age, it was decreased or rather it plateaued. Above 40years of age, large and small arterial compliance levels were significantly decreased with advancing age. Small arterial compliance was much more decreased than large arterial compliance. In hypertensive subjects, small and large arterial compliance levels were significantly decreased in comparison with normotensive subjects. Benidipine hydrochloride 8mg was given orally every morning in elderly hypertensive patients for at least 1month, and blood pressure and arterial compliance were measured every week using CR-2000. Benidipine hydrochloride decreased blood pressure and improved arterial compliance gradually and safely without any adverse effect. Therefore, benidipine hydrochloride is thought to be a useful antihypertensive drug for elderly hypertensives because of its potential to improve arterial function and perhaps arterial properties.</description><dc:title>The effect of hypertension, aging and benidipine on arterial elasticity in elderly hypertensives</dc:title><dc:creator>Tetsuhiro Umeno, Toshio Shimada, Hironori Tsukihashi, Nobuyuki Oyake, Yo Murakami, Nobuyuki Takahashi, Kazuaki Tanabe, Osamu Doi, Hirofumi Kambara, Akira Matsumori</dc:creator><dc:identifier>10.1016/j.cvdpc.2010.04.004</dc:identifier><dc:source>CVD Prevention and Control 5, 2 (2010)</dc:source><dc:date>2010-06-14</dc:date><prism:publicationName>CVD Prevention and Control</prism:publicationName><prism:publicationDate>2010-06-14</prism:publicationDate><prism:volume>5</prism:volume><prism:number>2</prism:number><prism:issueIdentifier>S1875-4570(10)X0004-3</prism:issueIdentifier><prism:section>Articles</prism:section><prism:startingPage>45</prism:startingPage><prism:endingPage>50</prism:endingPage></item><item rdf:about="http://www.precon-journal.com/article/PIIS1875457010000550/abstract?rss=yes"><title>Leukocytes are the major target of hepatitis C virus infection: Possible mechanism of multiorgan involvement including the heart</title><link>http://www.precon-journal.com/article/PIIS1875457010000550/abstract?rss=yes</link><description>Summary: Chronic hepatitis C virus infection has been associated with several extrahepatic manifestations, among these, renal and cardiac involvement. However, morphological evidence of hepatitis C virus localization in various organs remains to be clarified.We used immunohistochemistry to analyze the hepatitis C virus core and nonstructural antigens. Peripheral blood mononuclear cells were obtained from four patients with hepatitis C virus infection. Liver, kidney, heart, and bone marrow were taken from autopsy specimens from nine patients with hepatocellular carcinoma and three patients with cardiomyopathies with positive hepatitis C virus infection.Antibody against hepatitis C virus core antigen stained peripheral blood mononuclear cells, and the majority of positive staining was seen in CD68-positive macrophages. Hepatitis C virus core and NS4 antibodies stained mostly infiltrating cells in the liver, heart, kidney, and bone marrow, but not hepatocytes, myocytes, or globular cells. Serial sections stained by CD68, CD3, and CD20 antibodies showed that most of the hepatitis C virus-positive cells were CD68-positive macrophages.We demonstrate for the first time clear distribution of hepatitis C virus antigen in mononuclear cells in various organs from patients with hepatitis C virus infection. This study suggests that macrophages are the major target of hepatitis C virus infection.</description><dc:title>Leukocytes are the major target of hepatitis C virus infection: Possible mechanism of multiorgan involvement including the heart</dc:title><dc:creator>Akira Matsumori, Miho Shimada, Tsutomu Obata</dc:creator><dc:identifier>10.1016/j.cvdpc.2010.04.005</dc:identifier><dc:source>CVD Prevention and Control 5, 2 (2010)</dc:source><dc:date>2010-06-14</dc:date><prism:publicationName>CVD Prevention and Control</prism:publicationName><prism:publicationDate>2010-06-14</prism:publicationDate><prism:volume>5</prism:volume><prism:number>2</prism:number><prism:issueIdentifier>S1875-4570(10)X0004-3</prism:issueIdentifier><prism:section>Articles</prism:section><prism:startingPage>51</prism:startingPage><prism:endingPage>58</prism:endingPage></item><item rdf:about="http://www.precon-journal.com/article/PIIS1875457010000574/abstract?rss=yes"><title>Metabolic syndrome and cardiovascular risk in diabetic subjects</title><link>http://www.precon-journal.com/article/PIIS1875457010000574/abstract?rss=yes</link><description>Summary: There are divergent criteria for the identification of metabolic syndrome (MetS), but all the definitions agree that obesity, insulin resistance, dyslipidemia and hypertension are core components of this syndrome. The MetS is associated with an increased risk of cardiovascular disease events in general populations. Well-designed prospective studies in Asian populations are very limited. This study characterizes nine parameters of the MetS in a population of diabetic patients without a history of cardiovascular disease in Bangladesh, and defines the influence of MetS on peripheral vascular disease. A total of 100 patients with diabetes who visited the outpatient department of BIRDEM for routine diabetic follow-up were included in this study. The prevalence of MetS was 66%. Sixty-seven percent of patients had a waist circumference above normal, 89% hypertriglyceridemia, and 87% a low HDL-C level, while elevated systolic blood pressure was found in 46% and diastolic blood pressure in 55%, according to IDF criteria. Peripheral vascular disease defined by a low ankle-brachial index (&lt;0.9) was identified in 24% of patients with no history of a cardiovascular event.</description><dc:title>Metabolic syndrome and cardiovascular risk in diabetic subjects</dc:title><dc:creator>Faria Afsana, Zafar A. Latif, Shah J. Khan, Samir K. Talukder</dc:creator><dc:identifier>10.1016/j.cvdpc.2010.05.001</dc:identifier><dc:source>CVD Prevention and Control 5, 2 (2010)</dc:source><dc:date>2010-06-14</dc:date><prism:publicationName>CVD Prevention and Control</prism:publicationName><prism:publicationDate>2010-06-14</prism:publicationDate><prism:volume>5</prism:volume><prism:number>2</prism:number><prism:issueIdentifier>S1875-4570(10)X0004-3</prism:issueIdentifier><prism:section>Articles</prism:section><prism:startingPage>59</prism:startingPage><prism:endingPage>62</prism:endingPage></item><item rdf:about="http://www.precon-journal.com/article/PIIS1875457010000562/abstract?rss=yes"><title>Picture my heart: Reflections on cardiovascular care in developing countries</title><link>http://www.precon-journal.com/article/PIIS1875457010000562/abstract?rss=yes</link><description>China, India and Indonesia, three of the four most populous countries in the world, now account for over 40% of the world’s population . Advancement in communication technology in the last decade of the 20th Century allowed for the emergence of a virtual global village, accelerating the socio-economic development in these and other developing countries, particularly those in South and East Asia. Malaysia, with its balanced, multiethnic population (predominantly Chinese, Indian and Malay), is no stranger to this phenomenon – it envisages a developed country status by the year 2020, and has taken aggressive steps to achieving this target.</description><dc:title>Picture my heart: Reflections on cardiovascular care in developing countries</dc:title><dc:creator>A.Y.Y. Fong, K.H. Sim</dc:creator><dc:identifier>10.1016/j.cvdpc.2010.04.006</dc:identifier><dc:source>CVD Prevention and Control 5, 2 (2010)</dc:source><dc:date>2010-06-14</dc:date><prism:publicationName>CVD Prevention and Control</prism:publicationName><prism:publicationDate>2010-06-14</prism:publicationDate><prism:volume>5</prism:volume><prism:number>2</prism:number><prism:issueIdentifier>S1875-4570(10)X0004-3</prism:issueIdentifier><prism:section>Short Communication</prism:section><prism:startingPage>63</prism:startingPage><prism:endingPage>64</prism:endingPage></item><item rdf:about="http://www.precon-journal.com/article/PIIS1875457010000689/abstract?rss=yes"><title>Calendar</title><link>http://www.precon-journal.com/article/PIIS1875457010000689/abstract?rss=yes</link><description></description><dc:title>Calendar</dc:title><dc:creator></dc:creator><dc:identifier>10.1016/S1875-4570(10)00068-9</dc:identifier><dc:source>CVD Prevention and Control 5, 2 (2010)</dc:source><dc:date>2010-06-01</dc:date><prism:publicationName>CVD Prevention and Control</prism:publicationName><prism:publicationDate>2010-06-01</prism:publicationDate><prism:volume>5</prism:volume><prism:number>2</prism:number><prism:issueIdentifier>S1875-4570(10)X0004-3</prism:issueIdentifier><prism:section></prism:section><prism:startingPage>I</prism:startingPage><prism:endingPage>II</prism:endingPage></item></rdf:RDF>